Rare sugars curb appetite and mimic diabetes drugs in mice
Can rare sugars help control appetite and fight obesity? New research in mice suggests sweet solutions may lie in your ...
Tag: Glucagon-like Peptide-1
What causes behavioral side effects in popular weight loss drugs?
GLP1R gene variants link to cardiometabolic traits and behavioral changes, but findings suggest behavioral effects of GLP1RA are indirect Study: ...
Benefits and risks of popular weight-loss drugs revealed
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...
Nearly half of weight loss participants reduced alcohol use after starting anti-obesity medication
Anti-obesity medications linked to reduced alcohol use, possibly due to effects on cravings and reward systems, with behavioral strategies also ...
GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder
A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential ...
GLP-1 receptor agonists show promise in treating substance use disorders
A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due ...
Clarification urgently needed for detected signal of semaglutide-linked suicidal ideation
Study: Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality. Image Credit: myskin / Shutterstock.com In a recent ...
Sustainable weight loss with personalized semaglutide dosing
New research being presented at the European Congress on Obesity (ECO) in Venice, Italy (12-15 May) has explored the benefits ...
Groundbreaking studies indicate Semaglutide and Tirzepatide may reduce alcohol consumption in individuals with obesity
In a recent study published in Scientific Reports, researchers evaluated the impact of semaglutide and tirzepatide medications on alcohol consumption ...